Guselkumab, a medication with a mechanism of action that is new to inflammatory bowel disease (IBD) treatment, outperformed ...

Intravenous induction followed by subcutaneous maintenance therapy with guselkumab is efficacious for adults with moderately ...

Pediatric hidradenitis suppurativa faces diagnostic delays and stigma, while adalimumab shows superior drug survival compared ...

Ustekinumab is associated with a higher rate of clinical remission at 6 months compared with anti-TNF therapy among patients with CLDP. Ustekinumab may be more effective than anti-tumor necrosis ...

More than 36,300 people are claiming PIP or ADP for gastrointestinal conditions including Crohn’s, Colitis and Coeliac ...

A majority of patients with inflammatory bowel disease (IBD) said they felt marijuana and CBD were “beneficial” and provided ...

Neuroscientific Biopharmaceuticals has snagged a well-credentialled WA haematologist and oncologist as its chief medical ...

More than 90 percent of Americans aren’t getting enough of the critical carb that can protect against heart disease and ...

On the runway, a dozen wearable pieces designed by Denton artist and activist Emily Cavender mainly represented invisible ...

Gut support cells communicate with surprising precision – like brain neurons – using tiny extensions to send instructions to ...

Alarming new report reveals 290,000 children are at risk of serious, long-term health problems because of the air they ...